Randomised trial spacer v nebuliser for acute asthma

P C Parkin; N R Saunders; S A Diamond; P M Winders; C Macarthur

doi:10.1136/adc.72.3.239

Randomised trial spacer v nebuliser for acute asthma

Arch Dis Child. 1995 Mar;72(3):239-40. doi: 10.1136/adc.72.3.239.

Authors

P C Parkin¹, N R Saunders, S A Diamond, P M Winders, C Macarthur

Affiliation

¹ Division of General Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.

Abstract

Sixty hospitalised children with asthma aged 1-5 years were randomised to spacer or nebuliser. A clinical score was measured at baseline and every 12 hours. There were no differences between groups in the score over time, or secondary outcome measures. The spacer is an effective delivery method for young hospitalised asthmatic children.

Publication types

Clinical Trial
Comparative Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Administration, Inhalation
Albuterol / administration & dosage*
Asthma / drug therapy*
Child, Preschool
Drug Delivery Systems
Drug Therapy, Combination
Humans
Infant
Ipratropium / administration & dosage
Nebulizers and Vaporizers*

Substances

Ipratropium
Albuterol